Protein aggregate spreading in neurodegenerative diseases: Problems and perspectives

• Published in: Neuroscience research Vol. 70; no. 4; pp. 339 - 348
• Main Authors: Lee, Seung-Jae, Lim, Hee-Sun, Masliah, Eliezer, Lee, He-Jin
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier Ireland Ltd 01.08.2011
• Subjects: Alzheimer's disease; Animals; Humans; Huntington's disease; Nerve Tissue Proteins - chemistry; Nerve Tissue Proteins - metabolism; Neurodegenerative Diseases - metabolism; Neurodegenerative Diseases - pathology; Parkinson's disease; Prion; Protein aggregation; Protein Folding; Proteostasis Deficiencies - metabolism; Proteostasis Deficiencies - pathology; APP; Protein aggregation; AD; Parkinson's disease; CNS; NTs; Huntington's disease; Aβ; NFTs; PD; Prion; polyQ; CJD; HD; Alzheimer's disease
• ISSN: 0168-0102; 1872-8111
• DOI: 10.1016/j.neures.2011.05.008

Progressive accumulation of specific protein aggregates is a defining feature of many major neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, fronto-temporal dementia, Huntington's disease, and Creutzfeldt–Jakob disease (CJD). Findings from several recent studies have suggested that aggregation-prone proteins, such as tau, α-synuclein, polyglutamine-containing proteins, and amyloid-β, can spread to other cells and brain regions, a phenomenon considered unique to prion disorders, such as CJD and bovine spongiform encephalopathy. Cell-to-cell propagation of protein aggregates may be the general underlying principle for progressive deterioration of neurodegenerative diseases. This may also have significant implications in cell replacement therapies, as evidenced by the propagation of α-synuclein aggregates from host to grafted cells in long-term transplants in Parkinson's patients. Here, we review recent progress in protein aggregate propagation in experimental model systems and discuss outstanding questions and future perspectives. Understanding the mechanisms of this pathological spreading may open the way to unique opportunities for development of diagnostic techniques and novel therapies for protein misfolding-associated neurodegenerative diseases.